Elite Pharmaceuticals, Inc. (ELTP) Reports Q3 EPS of $0.00

February 14, 2024 4:58 PM EST

Elite Pharmaceuticals, Inc. (OTC: ELTP) reported Q3 EPS of $0.00. Revenue for the quarter came in at $15.54 million.

For earnings history and earnings-related data on Elite Pharmaceuticals, Inc. (ELTP) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings